| Langerhans cell histiocytosis: diagnosis, natural history, management, and outcome | Cancer | 1999 | 441 |
| Epstein-Barr virus-induced posttransplant lymphoproliferative disorders. ASTS/ASTP EBV-PTLD Task Force and The Mayo Clinic Organized International Consensus Development Meeting | Transplantation | 1999 | 417 |
| Amyloidosis | Hematology/Oncology Clinics of North America | 1999 | 130 |
| Phase II trial of primary chemotherapy followed by reduced-dose radiation for CNS germ cell tumors | Journal of Clinical Oncology | 1999 | 127 |
| Prognostic factors in multiple myeloma | Hematology/Oncology Clinics of North America | 1999 | 81 |
| Cytogenetic abnormalities correlate with the plasma cell labeling index and extent of bone marrow involvement in myeloma | Cancer Genetics and Cytogenetics | 1999 | 79 |
| Cryoglobulinemia | Hematology/Oncology Clinics of North America | 1999 | 77 |
| The role of interleukin-1 beta in the pathogenesis of multiple myeloma | Hematology/Oncology Clinics of North America | 1999 | 71 |
| Comparison of Interleukin-1β Expression by In Situ Hybridization in Monoclonal Gammopathy of Undetermined Significance and Multiple Myeloma | Blood | 1999 | 69 |
| Epstein-Barr virus infection in Richter's transformation | American Journal of Hematology | 1999 | 69 |
| Monoclonal gammopathies of undetermined significance | Hematology/Oncology Clinics of North America | 1999 | 69 |
| Osseous Hodgkin disease | Cancer | 1999 | 63 |
| Acquired Fanconi's syndrome associated with monoclonal gammopathies | Hematology/Oncology Clinics of North America | 1999 | 40 |
| Case of granulocyte colony-stimulating factor-induced Sweet's syndrome | American Journal of Hematology | 1999 | 37 |
| Is flow cytometric DNA content hypodiploidy prognostic in multiple myeloma? | Leukemia and Lymphoma | 1999 | 34 |
| Concurrent inflammatory bowel disease and myelodysplastic syndromes | Inflammatory Bowel Diseases | 1999 | 29 |
| Thrombosis related to the use of L-asparaginase in adults with acute lymphoblastic leukemia: a need to consider coagulation monitoring and clotting factor replacement | Leukemia and Lymphoma | 1999 | 26 |
| Autoimmune factor VIII inhibitors | Current Opinion in Hematology | 1999 | 25 |
| Cytogenetic abnormalities in multiple myeloma | Hematology/Oncology Clinics of North America | 1999 | 21 |
| Blood transfusion and risk of non-Hodgkin's lymphoma | American Journal of Epidemiology | 1999 | 21 |
| Comparison of interleukin-1 beta expression by in situ hybridization in monoclonal gammopathy of undetermined significance and multiple myeloma | Blood | 1999 | 14 |
| The role of adhesion receptors in the pathogenesis of multiple myeloma | Hematology/Oncology Clinics of North America | 1999 | 12 |
| Clinical aspects of multiple myeloma and related disorders including amyloidosis | Pathologie Et Biologie | 1999 | 11 |
| Prevention of recurrence and prolonged survival in primary central nervous system lymphoma (PCNSL) patients treated with adjuvant high-dose methylprednisolone | Medical Oncology and Tumor Pharmacotherapy | 1999 | 10 |
| Facilitation of plasminogen activation by denatured prothrombin | Thrombosis Research | 1999 | 5 |
